Autolus Therapeutics Ltd | AUTL - Gross Profit On Sales

Stock Price
1.43
Daily Change
-0.03 -1.72%
Monthly
-14.67%
Yearly
-14.93%
Q1 Forecast
1.41

Autolus Therapeutics Ltd reported $-7.45M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 5M Dec/2025
Autolus Therapeutics Ltd USD -7.45M 3.93M Sep/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Novartis USD 10.25B 570M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Silence Therapeutics USD 185.47K 1.82M Jun/2025